97 related articles for article (PubMed ID: 8509042)
21. [The therapeutic use of diucifon-activated immunocytes in adoptive transfer in mice with burn trauma complicated by Pseudomonas aeruginosa infection].
Prozorovskiĭ NS; Radkevich SA; Radchenkov VP; Moroz AF; Leskov VP; Gushchin IS
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):55-8. PubMed ID: 1858473
[TBL] [Abstract][Full Text] [Related]
22. The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients.
Reyes E; Carballido J; Manzano L; Moltó L; Olivier C; Alvarez-Mon M
Br J Cancer; 1999 Mar; 79(7-8):1162-7. PubMed ID: 10098752
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte subpopulations in peripheral blood in primary sclerosing cholangitis.
Panasiuk A; Prokopowicz D; Zak J; Panasiuk B; Wysocka J
Hepatogastroenterology; 2004; 51(59):1289-91. PubMed ID: 15362735
[TBL] [Abstract][Full Text] [Related]
24. [Diucifon in the therapy of dermatoses].
Grebeniuk VN; Fedorova EG; Sheklakova MN
Vestn Dermatol Venerol; 1980 Feb; (2):41-3. PubMed ID: 6986724
[No Abstract] [Full Text] [Related]
25. [Correction of secondary immunodeficiency as a method of prevention of suppurative-septic complications after surgery with artificial blood circulation].
Vinnitskiĭ LI; Mironova EV; Buniatian KA; Inviiaeva EV
Anesteziol Reanimatol; 2000; (5):46-9. PubMed ID: 11220936
[TBL] [Abstract][Full Text] [Related]
26. [Immunotherapy of pulmonary tuberculosis].
Khudzik LB; Salina TIu; Parolina LE
Probl Tuberk; 1998; (6):23-6. PubMed ID: 10067345
[TBL] [Abstract][Full Text] [Related]
27. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Plana M; Ferrer E; Martínez C; Podzamczer D; García F; Maleno MJ; Barceló JJ; García A; Barberá MJ; Lacarcel M; Miró JM; Gallart T; Gatell JM
Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
[TBL] [Abstract][Full Text] [Related]
28. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
29. [A trial of the use of the new Russian preparation oxymetacil in patients with chronic nonspecific lung diseases].
Borisova AM
Ter Arkh; 1995; 67(3):20-2. PubMed ID: 7770795
[TBL] [Abstract][Full Text] [Related]
30. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
Gori A; Trabattoni D; Bandera A; Saresella M; Marchetti G; Gazzola L; Biasin M; Rhodes J; McDade H; Panebianco R; Galli M; Moroni M; Ferrante P; Thomas N; Franzetti F; Bray D; Clerici M
Antivir Ther; 2004 Aug; 9(4):603-14. PubMed ID: 15456092
[TBL] [Abstract][Full Text] [Related]
32. Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.
Richards J; Auger J; Peace D; Gale D; Michel J; Koons A; Haverty T; Zivin R; Jolliffe L; Bluestone JA
Cancer Res; 1999 May; 59(9):2096-101. PubMed ID: 10232594
[TBL] [Abstract][Full Text] [Related]
33. The effect of supplemental beta-carotene on immunologic indices in patients with AIDS: a pilot study.
Fryburg DA; Mark RJ; Griffith BP; Askenase PW; Patterson TF
Yale J Biol Med; 1995; 68(1-2):19-23. PubMed ID: 8748463
[TBL] [Abstract][Full Text] [Related]
34. The changes in T lymphocyte subsets following periodontal treatment in patients with chronic periodontitis.
Erciyas K; Orbak R; Kavrut F; Demir T; Kaya H
J Periodontal Res; 2006 Jun; 41(3):165-70. PubMed ID: 16677283
[TBL] [Abstract][Full Text] [Related]
35. [The treatment of the acute complications of gonococcal infection].
Kornelishin NF
Vestn Dermatol Venerol; 1990; (8):57-60. PubMed ID: 2256383
[TBL] [Abstract][Full Text] [Related]
36. [Difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia].
Li MH; Li XH; Li XW; Ma L; Yi W; Jiang YY; Dong JP; Li WL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Jun; 18(2):137-41. PubMed ID: 15340501
[TBL] [Abstract][Full Text] [Related]
37. [Immunomodulating therapy of middle-aged and elderly patients with erysipelas].
Frolov VM; Rychnev VE; Razenkova AT; Baskakov IN; Gurina AA
Vrach Delo; 1987 Jul; (7):103-5. PubMed ID: 3630100
[No Abstract] [Full Text] [Related]
38. [Selected lymphocyte subsets in Lime borreliosis: a preliminary study].
Zajkowska JM; Hermanowska-Szpakowicz T; Kasprzycka E
Pol Merkur Lekarski; 1999 May; 6(35):259-62. PubMed ID: 10437395
[TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration.
Tanaka S; Masuda M; Nakajima K; Ido N; Ohtsuka T; Nishida M; Utsumi H; Hirano T
Int Immunopharmacol; 2009 Mar; 9(3):284-90. PubMed ID: 19101657
[TBL] [Abstract][Full Text] [Related]
40. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
